Flagship Biosciences, Inc. — Form D

Flagship Biosciences, Inc. of BROOMFIELD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-16. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Gary M ClarkDirectorWestminster, CO
Nancy A GillettDirectorWestminster, CO
Gregory K TuckerDirectorWestminster, CO
Dean David NortheyExecutive OfficerWestminster, CO
William SniderDirectorBethesda, MD
Paul KirchgraberDirectorBroomfield, CO
Trevor JohnsonDirectorBroomfield, CO
Trevor JohnsonExecutive OfficerBroomfield, CO
Trevor JohnsonPromoterBroomfield, CO
Tom TuriDirectorBroomfield, CO
Tom TuriExecutive OfficerBroomfield, CO
Herb HooperDirectorBroomfield, CO
Bill H SniderDirectorBroomfield, CO
Fisher AaronDirectorBroomfield, CO
Herb H HooperDirectorBroomfield, CO
Tom H TuriDirectorBroomfield, CO
Joe Dean KrugerExecutive OfficerWestminster, CO
Nancy Dean GillettDirectorWestminster, CO
G. David YoungDirectorWestminster, CO
G. David YoungExecutive OfficerWestminster, CO
G. David YoungPromoterWestminster, CO
Gary Dean ClarkDirectorWestminster, CO
L. Dean NortheyExecutive OfficerWestminster, CO
Holger Dean LangeExecutive OfficerWestminster, CO

Other filings by this issuer (5)

FiledFormOfferingSold
2024-04-18D$6.4M$5.0M
2024-02-21D/A$5.0M$3.0M
2023-12-14D$1.5M$1.5M
2022-09-09D$15.3M$15.3M
2018-07-09D$2.5M$2.5M

More